UPLOAD Filing
REVELATION BIOSCIENCES, INC.
Date: Feb. 6, 2026 · CIK: 0001810560 · Accession: 0000000000-26-001281
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293078
Letter
February 6, 2026 James Rolke Chief Executive Officer Revelation Biosciences, Inc. 4660 La Jolla Village Drive, Suite 100 San Diego, California 92122 Re:Revelation Biosciences, Inc. Registration Statement on Form S-3 Filed January 30, 2026 File No. 333-293078 Dear James Rolke: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Joseph P. Galda
Show Raw Text
February 6, 2026
James Rolke
Chief Executive Officer
Revelation Biosciences, Inc.
4660 La Jolla Village Drive, Suite 100
San Diego, California 92122
Re:Revelation Biosciences, Inc.
Registration Statement on Form S-3
Filed January 30, 2026
File No. 333-293078
Dear James Rolke:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Joseph P. Galda